Blog
RSS FeedPosted by Michael Wonder on 02 Feb 2017
AusBiotech consults biotech CEOs on industry advocacy
2 February 2017 - AusBiotech has launched its annual consultation of membership issues, calling for leaders of biotechnology companies to ...
Posted by Michael Wonder on 01 Feb 2017
Senate inquiry on prostheses pricing urged to consider implications
31 January 2017 - AusBiotech has made a submission to the Senate’s Community Affairs References Committee Inquiry into the ‘Price ...
Posted by Michael Wonder on 01 Feb 2017
Advanced ovarian cancer treatment placed on the PBS, a move praised by doctors and patients
1 January 2017 - Women with advanced ovarian cancer can now pay significantly less for a groundbreaking drug, in a ...
Posted by Michael Wonder on 31 Jan 2017
Schedule of Pharmaceutical Benefits - 1 February 2017 update
1 February 2017 - The 1 February 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 31 Jan 2017
Patients battling deadly ovarian, lung cancer to have affordable access to new drugs
31 January 2017 - Sick patients battling deadly cancers will have affordable access to new drugs which usually cost more ...
Posted by Michael Wonder on 30 Jan 2017
Rise in deadly W strain of Meningococcal disease prompts calls for national approach
30 January 2017 - A national approach to the deadly W strain of Meningococcal disease is being considered by Australia's ...
Posted by Michael Wonder on 29 Jan 2017
Check your health insurance because extras cover may not be worth it, say experts
29 January 2017 - Private health insurance members with extras cover should be doing a simple maths equation to work ...
Posted by Michael Wonder on 27 Jan 2017
Health insurers, customers hope for a win on premium increases
27 January 2017 - New health minister Greg Hunt could look to score a “win” with consumers and approve the ...
Posted by Michael Wonder on 27 Jan 2017
Post-market review of ezetimibe – draft report
27 January 2017 - Public consultation on the draft Report to the PBAC of the post-market review of ezetimibe is ...
Posted by Michael Wonder on 27 Jan 2017
Recommendations made by the PBAC - December 2016
27 January 2016 - The outcomes from the December 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 25 Jan 2017
Bupa warns health insurers face unsustainable cost increases
26 January 2017 - Bupa has warned the Turnbull government that affordability concerns have driven the private health insurance sector ...
Posted by Michael Wonder on 25 Jan 2017
Woman plans to sell home to pay for pancreatic cancer treatment
24 January 2017 - A woman has been forced to sell her paintings, jewellery and now even her house after ...
Posted by Michael Wonder on 23 Jan 2017
Indicative 1 April 2017 prices - 2017 April cycle
23 January 2017 - Indicative 1 April 2017 prices resulting from the 2017 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 22 Jan 2017
Specialists’ fees drive up out-of-pocket costs for patients
23 January 2017 - Australian patients are increasingly being forced to pay higher out-of-pocket costs for common procedures, with some ...
Posted by Michael Wonder on 22 Jan 2017
Medicare levy increase on the table as Turnbull budget speculation begins
22 January 2017 - Doctors believe the Turnbull government could be contemplating another increase in the Medicare levy. ...